What is Dupont De Nemours Inc's earnings per share (EPS)?

Dupont De Nemours Inc (DD) reported diluted earnings per share of $-1.86 for fiscal year 2025. This represents a -210.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Dupont De Nemours Inc Financials

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Dupont De Nemours Inc (DD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DD FY2025 2026-05-05

A leaner balance sheet did not create better cash economics: revenue stayed near $6.8B while surplus cash thinned.

From FY2023 to FY2025, gross margin recovered from 32.8% to 34.5%, yet free cash flow fell and net income nearly disappeared, so the pressure clearly sits below production costs rather than in basic manufacturing efficiency. That helps explain why a business with roughly steady sales ended FY2025 with only $227M of free cash flow and just $88M of net income.

Management also kept shrinking the balance sheet: total liabilities dropped to $7.5B in FY2025 from $12.8B a year earlier, which lowers financing burden but also reflects a much smaller asset base. With goodwill still occupying a large share of assets, the leaner structure is not simply more cash-rich; a meaningful portion of what remains is still acquisition-created value.

In FY2025, dividends were not covered by free cash flow: payouts were $597M against only $227M of FCF. Cash ended at $715M after being $1.8B in FY2024, so distributions and deleveraging together used liquidity faster than the business replenished it.

Financial Health Signals

Financial Profile 39/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Dupont De Nemours Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Dupont De Nemours Inc's revenue grew a modest 1.9% year-over-year to $6.8B. This slow but positive growth earns a score of 36/100.

Leverage

Dupont De Nemours Inc carries a low D/E ratio of 0.23, meaning only $0.23 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Dupont De Nemours Inc's current ratio of 2.42 indicates adequate short-term liquidity, earning a score of 45/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Dupont De Nemours Inc has a free cash flow margin of 3.3%, earning a moderate score of 39/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Dupont De Nemours Inc generates a 0.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 15/100. This is down from 3.0% the prior year.

Piotroski F-Score Strong

7/9

Dupont De Nemours Inc passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

6.36x

For every $1 of reported earnings, Dupont De Nemours Inc generates $6.36 in operating cash flow ($560.0M OCF vs $88.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.8B

YoY+1.9%

5Y CAGR-13.7%

10Y CAGR-17.8%

Dupont De Nemours Inc generated $6.8B in revenue in fiscal year 2025. This represents an increase of 1.9% from the prior year.

EBITDA

N/A

Net Income

$88.0M

YoY-87.5%

10Y CAGR-36.0%

Dupont De Nemours Inc reported $88.0M in net income in fiscal year 2025. This represents a decrease of 87.5% from the prior year.

EPS (Diluted)

$-1.86

YoY-210.7%

Dupont De Nemours Inc earned $-1.86 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 210.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$227.0M

YoY-52.7%

5Y CAGR-39.9%

10Y CAGR-24.8%

Dupont De Nemours Inc generated $227.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 52.7% from the prior year.

Cash & Debt

$715.0M

YoY-60.1%

5Y CAGR-22.4%

10Y CAGR-22.0%

Dupont De Nemours Inc held $715.0M in cash against $3.1B in long-term debt as of fiscal year 2025.

Dividends Per Share

$1.43

YoY-5.9%

5Y CAGR+3.6%

Dupont De Nemours Inc paid $1.43 per share in dividends in fiscal year 2025. This represents a decrease of 5.9% from the prior year.

Shares Outstanding

409M

YoY-2.2%

5Y CAGR-5.3%

Dupont De Nemours Inc had 409M shares outstanding in fiscal year 2025. This represents a decrease of 2.2% from the prior year.

Margins & Returns

Gross Margin

34.5%

YoY+1.5pp

5Y CAGR-16.2pp

10Y CAGR+11.9pp

Dupont De Nemours Inc's gross margin was 34.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.5 percentage points from the prior year.

Operating Margin

N/A

Net Margin

1.3%

YoY-9.2pp

5Y CAGR+21.9pp

10Y CAGR-14.5pp

Dupont De Nemours Inc's net profit margin was 1.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 9.2 percentage points from the prior year.

Return on Equity

0.6%

YoY-2.4pp

5Y CAGR+8.3pp

10Y CAGR-28.7pp

Dupont De Nemours Inc's ROE was 0.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.4 percentage points from the prior year.

Capital Allocation

R&D Spending

$193.0M

YoY-4.9%

5Y CAGR-19.3%

10Y CAGR-19.1%

Dupont De Nemours Inc invested $193.0M in research and development in fiscal year 2025. This represents a decrease of 4.9% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$333.0M

YoY+16.8%

5Y CAGR-22.5%

10Y CAGR-21.4%

Dupont De Nemours Inc invested $333.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 16.8% from the prior year.

DD Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$6.8B+1.9%	$6.7B+1.6%	$6.6B-49.2%	$13.0B+3.6%	$12.6B-12.4%	$14.3B
Cost of Revenue	$4.5B-0.3%	$4.5B+1.3%	$4.4B-47.1%	$8.4B+5.4%	$8.0B+12.9%	$7.1B
Gross Profit	$2.4B+6.4%	$2.2B+2.2%	$2.2B-52.9%	$4.6B+0.4%	$4.6B-36.8%	$7.3B
R&D Expenses	$193.0M-4.9%	$203.0M+5.7%	$192.0M-64.2%	$536.0M-3.8%	$557.0M-1.4%	$565.0M
SG&A Expenses	$1.0B+4.4%	$976.0M+9.5%	$891.0M-39.3%	$1.5B-8.4%	$1.6B+7.4%	$1.5B
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$313.0M-14.5%	$366.0M-7.6%	$396.0M-19.5%	$492.0M-6.3%	$525.0M-21.9%	$672.0M
Income Tax	$102.0M-52.1%	$213.0M+198.2%	-$217.0M-156.1%	$387.0M+63.3%	$237.0M+163.3%	$90.0M
Net Income	$88.0M-87.5%	$703.0M+66.2%	$423.0M-92.8%	$5.9B-9.3%	$6.5B+319.1%	-$3.0B
EPS (Diluted)	$-1.86-210.7%	$1.68+78.7%	$0.94-92.0%	$11.75-1.2%	$11.89+396.5%	$-4.01

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$1.7B-0.7%	$1.7B-5.7%	$1.8B+2.6%	$1.7B+8.5%	$1.6B-4.6%	$1.7B-1.5%	$1.7B-0.2%	$1.7B
Cost of Revenue	$1.1B-1.5%	$1.1B-7.1%	$1.2B+3.1%	$1.1B+6.9%	$1.1B-5.9%	$1.1B+0.2%	$1.1B+0.3%	$1.1B
Gross Profit	$602.0M+0.7%	$598.0M-2.9%	$616.0M+1.7%	$606.0M+11.6%	$543.0M-1.8%	$553.0M-4.7%	$580.0M-1.0%	$586.0M
R&D Expenses	$47.0M	N/A	$140.0M-1.4%	$142.0M+184.0%	$50.0M	N/A	$127.0M-5.2%	$134.0M
SG&A Expenses	$255.0M	N/A	$387.0M-4.4%	$405.0M+73.1%	$234.0M	N/A	$368.0M-12.0%	$418.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$40.0M	N/A	$99.0M+17.9%	$84.0M+1.2%	$83.0M	N/A	$87.0M-12.1%	$99.0M
Income Tax	$31.0M	N/A	$19.0M-72.1%	$68.0M+300.0%	$17.0M	N/A	$99.0M-17.5%	$120.0M
Net Income	$161.0M+227.8%	-$126.0M-2.4%	-$123.0M-308.5%	$59.0M+110.0%	-$589.0M-403.4%	-$117.0M-125.8%	$454.0M+155.1%	$178.0M
EPS (Diluted)	$0.39+230.0%	$-0.30-3.4%	$-0.29-307.1%	$0.14+110.0%	$-1.40-400.0%	$-0.28-125.9%	$1.08+151.2%	$0.43

DD Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$21.6B-41.1%	$36.6B-5.0%	$38.6B-6.8%	$41.4B-9.5%	$45.7B-35.5%	$70.9B
Current Assets	$5.6B-73.2%	$20.8B+176.5%	$7.5B-33.3%	$11.3B-21.2%	$14.3B-50.7%	$29.0B
Cash & Equivalents	$715.0M-60.1%	$1.8B-25.1%	$2.4B-34.7%	$3.7B+85.7%	$2.0B-22.5%	$2.5B
Inventory	$1.2B+3.7%	$1.1B-47.4%	$2.1B-7.8%	$2.3B+11.6%	$2.1B-12.8%	$2.4B
Accounts Receivable	$910.0M+15.3%	$789.0M-47.9%	$1.5B-3.4%	$1.6B-2.8%	$1.6B-12.9%	$1.9B
Goodwill	$7.9B+4.7%	$7.6B-1.3%	$7.7B-54.0%	$16.7B-1.9%	$17.0B+5.9%	$16.0B
Total Liabilities	$7.5B-41.8%	$12.8B-7.1%	$13.8B-3.6%	$14.3B-23.1%	$18.7B-41.4%	$31.8B
Current Liabilities	$2.3B-58.1%	$5.5B+77.4%	$3.1B-17.0%	$3.7B-24.3%	$4.9B-59.7%	$12.2B
Long-Term Debt	$3.1B-41.1%	$5.3B-32.3%	$7.9B-3.5%	$8.1B-23.4%	$10.6B-31.9%	$15.6B
Total Equity	$13.9B-40.4%	$23.4B-3.8%	$24.3B-8.6%	$26.6B+0.5%	$26.4B-31.3%	$38.5B
Retained Earnings	-$24.3B-5.2%	-$23.1B-0.9%	-$22.9B-8.6%	-$21.1B+9.2%	-$23.2B-100.1%	-$11.6B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$21.4B-0.6%	$21.6B-43.3%	$38.0B+4.1%	$36.6B+1.6%	$36.0B-1.8%	$36.6B-2.2%	$37.5B+2.5%	$36.6B
Current Assets	$5.6B+1.2%	$5.6B-44.4%	$10.0B+46.3%	$6.8B+6.0%	$6.5B-68.9%	$20.8B+222.6%	$6.4B+4.5%	$6.2B
Cash & Equivalents	$710.0M-0.7%	$715.0M-63.4%	$2.0B+6.4%	$1.8B+4.3%	$1.8B-1.7%	$1.8B+8.9%	$1.6B+9.4%	$1.5B
Inventory	$1.2B+3.2%	$1.2B-36.3%	$1.8B-19.9%	$2.3B+2.4%	$2.2B+98.4%	$1.1B-49.5%	$2.2B+3.4%	$2.2B
Accounts Receivable	N/A	$910.0M	N/A	N/A	N/A	$789.0M	N/A	N/A
Goodwill	$7.9B-0.6%	$7.9B-51.2%	$16.2B-0.1%	$16.2B+1.8%	$15.9B+110.9%	$7.6B-55.2%	$16.9B+1.9%	$16.6B
Total Liabilities	$7.2B-3.5%	$7.5B-49.2%	$14.7B+12.7%	$13.0B+2.6%	$12.7B-1.0%	$12.8B+0.3%	$12.8B+0.1%	$12.8B
Current Liabilities	$2.1B-8.8%	$2.3B-53.9%	$5.0B+3.1%	$4.9B+4.8%	$4.6B-15.7%	$5.5B+94.5%	$2.8B+1.4%	$2.8B
Long-Term Debt	$3.1B-0.1%	$3.1B-55.5%	$7.0B+32.4%	$5.3B0.0%	$5.3B0.0%	$5.3B-25.8%	$7.2B0.0%	$7.2B
Total Equity	$14.0B+0.9%	$13.9B-39.2%	$22.9B-0.7%	$23.1B+1.0%	$22.8B-2.2%	$23.4B-3.6%	$24.2B+3.8%	$23.3B
Retained Earnings	-$24.2B+0.3%	-$24.3B-2.3%	-$23.7B-0.5%	-$23.6B+0.2%	-$23.7B-2.6%	-$23.1B-0.5%	-$23.0B+1.9%	-$23.4B

DD Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$560.0M-26.8%	$765.0M-9.5%	$845.0M+43.7%	$588.0M-74.2%	$2.3B-44.3%	$4.1B
Capital Expenditures	$333.0M+16.8%	$285.0M-5.6%	$302.0M-54.4%	$662.0M-16.0%	$788.0M-34.0%	$1.2B
Free Cash Flow	$227.0M-52.7%	$480.0M-11.6%	$543.0M+833.8%	-$74.0M-105.0%	$1.5B-48.5%	$2.9B
Investing Cash Flow	N/A	N/A	N/A	$8.9B+471.6%	-$2.4B-1088.6%	-$202.0M
Financing Cash Flow	N/A	N/A	N/A	-$7.7B-17.8%	-$6.5B-301.0%	$3.2B
Dividends Paid	$597.0M-6.0%	$635.0M-2.5%	$651.0M-0.2%	$652.0M+3.5%	$630.0M-28.6%	$882.0M
Share Buybacks	N/A	N/A	N/A	N/A	$2.1B+823.7%	$232.0M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$232.0M+133.1%	-$700.0M-240.8%	$497.0M-27.6%	$686.0M+790.9%	$77.0M+110.2%	-$752.0M-251.3%	$497.0M-5.7%	$527.0M
Capital Expenditures	$102.0M+168.0%	-$150.0M-227.1%	$118.0M-51.4%	$243.0M+99.2%	$122.0M+234.1%	-$91.0M-235.8%	$67.0M-34.3%	$102.0M
Free Cash Flow	$130.0M+115.3%	-$850.0M-324.3%	$379.0M-14.4%	$443.0M+1084.4%	-$45.0M+94.7%	-$843.0M-296.0%	$430.0M+1.2%	$425.0M
Investing Cash Flow	N/A	N/A	N/A	-$111.0M+55.1%	-$247.0M	N/A	N/A	-$100.0M
Financing Cash Flow	N/A	N/A	N/A	-$184.0M+10.7%	-$206.0M	N/A	-$140.0M+83.3%	-$840.0M
Dividends Paid	$82.0M0.0%	$82.0M-52.3%	$172.0M+0.6%	$171.0M-0.6%	$172.0M+8.2%	$159.0M0.0%	$159.0M+0.6%	$158.0M
Share Buybacks	$500.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A

DD Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	34.5%+1.5pp	33.0%+0.2pp	32.8%-2.6pp	35.4%-1.1pp	36.6%-14.2pp	50.7%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	1.3%-9.2pp	10.5%+4.1pp	6.4%-38.7pp	45.1%-6.4pp	51.5%+72.0pp	-20.6%
Return on Equity	0.6%-2.4pp	3.0%+1.3pp	1.7%-20.4pp	22.1%-2.4pp	24.5%+32.1pp	-7.7%
Return on Assets	0.4%-1.5pp	1.9%+0.8pp	1.1%-13.1pp	14.2%+0.0pp	14.1%+18.3pp	-4.2%
Current Ratio	2.42-1.4	3.78+1.4	2.43-0.6	3.02+0.1	2.90+0.5	2.37
Debt-to-Equity	0.230.0	0.23-0.1	0.32+0.0	0.31-0.1	0.400.0	0.41
FCF Margin	3.3%-3.8pp	7.1%-1.1pp	8.2%+8.8pp	-0.6%-12.4pp	11.9%-8.3pp	20.2%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	35.8%+0.5pp	35.3%+1.0pp	34.3%-0.3pp	34.6%+1.0pp	33.7%+0.9pp	32.7%-1.1pp	33.8%-0.3pp	34.1%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	9.6%+17.0pp	-7.4%-0.6pp	-6.9%-10.2pp	3.4%+39.9pp	-36.5%-29.6pp	-6.9%-33.4pp	26.5%+16.1pp	10.4%
Return on Equity	1.1%+2.1pp	-0.9%-0.4pp	-0.5%-0.8pp	0.3%+2.8pp	-2.6%-2.1pp	-0.5%-2.4pp	1.9%+1.1pp	0.8%
Return on Assets	0.8%+1.3pp	-0.6%-0.3pp	-0.3%-0.5pp	0.2%+1.8pp	-1.6%-1.3pp	-0.3%-1.5pp	1.2%+0.7pp	0.5%
Current Ratio	2.68+0.3	2.42+0.4	2.00+0.6	1.41+0.0	1.40-2.4	3.78+1.5	2.28+0.1	2.21
Debt-to-Equity	0.220.0	0.23-0.1	0.31+0.1	0.230.0	0.230.0	0.23-0.1	0.30-0.0	0.31
FCF Margin	7.7%+57.9pp	-50.2%-71.3pp	21.1%-4.2pp	25.3%+28.1pp	-2.8%+47.1pp	-49.9%-75.0pp	25.1%+0.3pp	24.8%

Similar Companies

Ppg Inds Inc PPG

$23.1B

Air Prods & Chems Inc APD

$65.3B

Lyondellbasell Industries N V LYB

$23.9B

International Flavors&Fragranc IFF

$18.8B

Rpm Inc RPM

$12.4B

Frequently Asked Questions

What is Dupont De Nemours Inc's annual revenue?

Dupont De Nemours Inc (DD) reported $6.8B in total revenue for fiscal year 2025. This represents a 1.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Dupont De Nemours Inc's revenue growing?

Dupont De Nemours Inc (DD) revenue grew by 1.9% year-over-year, from $6.7B to $6.8B in fiscal year 2025.

Is Dupont De Nemours Inc profitable?

Yes, Dupont De Nemours Inc (DD) reported a net income of $88.0M in fiscal year 2025, with a net profit margin of 1.3%.

How much debt does Dupont De Nemours Inc have?

As of fiscal year 2025, Dupont De Nemours Inc (DD) had $715.0M in cash and equivalents against $3.1B in long-term debt.

What is Dupont De Nemours Inc's gross margin?

Dupont De Nemours Inc (DD) had a gross margin of 34.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Dupont De Nemours Inc's net profit margin?

Dupont De Nemours Inc (DD) had a net profit margin of 1.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Dupont De Nemours Inc pay dividends?

Yes, Dupont De Nemours Inc (DD) paid $1.43 per share in dividends during fiscal year 2025.

What is Dupont De Nemours Inc's return on equity (ROE)?

Dupont De Nemours Inc (DD) has a return on equity of 0.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Dupont De Nemours Inc's free cash flow?

Dupont De Nemours Inc (DD) generated $227.0M in free cash flow during fiscal year 2025. This represents a -52.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Dupont De Nemours Inc's operating cash flow?

Dupont De Nemours Inc (DD) generated $560.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Dupont De Nemours Inc's total assets?

Dupont De Nemours Inc (DD) had $21.6B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Dupont De Nemours Inc's capital expenditures?

Dupont De Nemours Inc (DD) invested $333.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Dupont De Nemours Inc spend on research and development?

Dupont De Nemours Inc (DD) invested $193.0M in research and development during fiscal year 2025.

How many shares does Dupont De Nemours Inc have outstanding?

Dupont De Nemours Inc (DD) had 409M shares outstanding as of fiscal year 2025.

What is Dupont De Nemours Inc's current ratio?

Dupont De Nemours Inc (DD) had a current ratio of 2.42 as of fiscal year 2025, which is generally considered healthy.

What is Dupont De Nemours Inc's debt-to-equity ratio?

Dupont De Nemours Inc (DD) had a debt-to-equity ratio of 0.23 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Dupont De Nemours Inc's return on assets (ROA)?

Dupont De Nemours Inc (DD) had a return on assets of 0.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Dupont De Nemours Inc's Piotroski F-Score?

Dupont De Nemours Inc (DD) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Dupont De Nemours Inc's earnings high quality?

Dupont De Nemours Inc (DD) has an earnings quality ratio of 6.36x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Dupont De Nemours Inc?

Dupont De Nemours Inc (DD) scores 39 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.